Addressing the Translatability and Delivery Outcomes of Lipid Nanoparticles Across a Spectrum of Research Models
Time: 9:30 am
day: Conference Day One
Details:
- Achieving an equilibrium between potency and toxicity during LNP screening
- Translating toxicity observations across various models to human in vivo trials to guarantee product safety
- Leveraging in vitro experimental insights to establish a foundational understanding for translation into in vivo settings
